Keywords

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
adolescents (1) Adult hippocampal neural progenitor cells (1) Aerobic exercise (1)
Age (1) Alzheimer's disease (1) Alzheimer’s disease (2)
amygdala (1) Amyloid (1) Antioxidant Enzymes (1)
apoptosis (2) autophagy (1) Biomarkers (4)
bonding strength (1) C3LP1 (1) Cancer biomarker detection; Arrayed nanostructured optical microdevices; Micromachined Fabry–Perot interferometer; Immunoassay (1)
Caspases (2) cell positioning (1) cell tracking (1)
child and adolescent psychiatry (1) children (1) choices (1)
Cholecystokinin (1) cloning (1) Cognition (1)
CRISPR (1) DAT-SPECT (1) dead cell (1)
decision time (1) development (1) diabetes mellitus (2)
Diagnostics (1) Differentiation (1) dopaminergic degeneration (1)
Droplet microfluidic device (1) Drug development (2) Drug development; Nanoformulation; Nanoneuromedicine; Nanotechnology; Targeting (1)
Drug effect analysis (1) dye molecule (1) electrical impedance (1)
electrical property (1) environmental factors (1) fluorescence image (1)
Fluorescence image analysis (1) fluorescence imaging (1) fluorodeoxyglucose F18 (2)
fMRI (1) food labeling (1) Fyn (1)
Gait; Parkinson disease; Rehabilitation (1) gene expression (1) genetic modification (1)
Green Tea (1) growth hormone (1) Guanosine Cyclohydrolase 1 (GCH1) (1)
HCS (1) her2 gene (1) high content screening (1)
High throughput (1) high throughput screening (1) Immunology (2)
Inflammation (2) insula (1) insulin resistance (2)
insulin resistance ; alzheimer's disease ; diabetes mellitus (1) Intravitreal transplantation (1) kinase (1)
live cell (1) lpha band; Beta band; Desynchronization; Hastening; Hypokinesia (1) magnetic resonance imaging (1)
manganese (3) Medial temporal lobe (1) Medicine (1)
Memory (3) Mesenchymal stem cells (1) metal mixtures (1)
metals (1) microfluidic channel (1) microfluidic chip (1)
microglia (1) Migration (1) mild cognitive impairment (1)
milk (1) mitochondria (1) Mitochondria-targeted antioxidant; Mitochondrial dysfunction; Neuroprotection; Oxidative stress; Parkinson's disease (1)
motor learning; procedural memory; practice; basal ganglia; skill acquisition; lesion studies (1) MRI (2) music therapy (1)
Nanoneuromedicine (1) nanoparticles (1) Nanotechnology (1)
nanotoxicology (1) neurodegeneration (2) Neurodegenerative disorders (1)
Neuroeconomics (1) neuroimaging (1) neuroinflammation (2)
Neuropathology (1) neurophysiology (1) neuroplascitity principles (1)
neuroprotection (1) Neurosphere (1) neurotoxicity (2)
neurotrophic factors (1) NFκB (1) NPTX2 (1)
oxidative stress (5) oxygen plasma (1) p300 (1)
Parkinson's disease (4) Parkinson's disease; IP6; Iron; MPP+ (1) Parkinson's Progression Marker Initiative (PPMI) (1)
Parkinson’s disease (5) Parkinson’s disease; metals; neuroprotection; neurotoxicity; protein aggregation; α-synuclein (1) Pentraxins (1)
phosphorylation (1) PKCdelta (2) PKCδ (1)
polymorphism (1) positron emission tomography (1) prefrontal cortex (1)
prion diseases (1) Protein kinase C (1) protein misfolding (1)
psychiatry (1) risk assessment (1) s Executive processing (1)
seal resistance (1) severe stress (1) sex differences (1)
single nucleotide (1) sMRI (1) statistical modeling (1)
Stroop (1) su8 mold (1) Tau (1)
Test Cardiorespiratory fitnes (1) transgenic (1) traumatic stress (1)
type 2 ; brain ; cognitive impairment ; fluorodeoxyglucose positron emission tomography ; brain imaging ; glucose uptake ; apolipoprotein e ; glucose metabolism (1) type 2 ; brain ; cognitive impairment ; fluorodeoxyglucose positron emission tomography ; brain imaging ; glucose uptake ; apolipoprotein e ; glucose metabolisminsulin resistance ; alzheimer's disease ; diabetes mellitus (1) vanadium (1)
Wisconsin Card Sort (1) α-synuclein (1)